Sullivan, Sean D., Grueger, Jens, Sullivan, Aidan P. and Ramsey, Scott D. (2025) The consequences of pharmaceutical tariffs in the United States. Journal of Managed Care & Specialty Pharmacy, 31 (6). 533 - 536. ISSN 2376-0540
Full text not available from this repository.Abstract
The Trump Administration has threatened to impose tariffs on imported branded, generic, and biosimilar pharmaceutical products. Although specific details regarding the exact rates and implementation timeline remain unclear, the administration has indicated that these tariffs will be substantial. Tariffs can create supply chain disruptions, increase costs, limit patient access to essential medications, and negatively impact research and innovation. Rather than punitive tariffs, industrial policy options and collaborative international treaties may better serve US economic and public health interests and lead to a more secure and consistent domestic supply of critical medicines.
| Item Type: | Article |
|---|---|
| Additional Information: | © 2025, Academy of Managed Care Pharmacy |
| Divisions: | Health Policy |
| Subjects: | R Medicine > RS Pharmacy and materia medica H Social Sciences > HF Commerce |
| Date Deposited: | 29 May 2025 13:27 |
| Last Modified: | 30 Jun 2025 00:00 |
| URI: | http://eprints.lse.ac.uk/id/eprint/128213 |
Actions (login required)
 |
View Item |
